LBX2 and non-small cell lung carcinoma: Overexpression of LBX2-AS1 has been reported in hepatocellular carcinoma, gastric cancer, non-small cell lung cancer and esophageal squamous cell carcinoma and it promoted cancer cell proliferation with different mechanism in different cell background [13–16].